ECOG-ACRIN E4412 – Phase II only

A Phase I Study with an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma

For more information about this clinical trial, click here

Schema & Eligibility ECOG-ACRIN E4412

Available at:

CoxHealth Medical Center, Springfield, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, Springfield, MO
Mercy Clinic, Rolla, MO
Mercy Hospital, St. Louis, MO

Ask your physician about participating in this clinical trial or call us.